Tested in animal models of acute myeloid leukemia, the new nanomedicine was dramatically more effective while also less toxic.

By restructuring a common chemotherapy drug, scientists increased its potency by 20,000 times. In a significant step forward for cancer therapy, researchers at Northwestern University have redesigned ...

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...

The FDA-approved drug Pluvicto offers hope for advanced prostate cancer patients, but access barriers remain despite proven ...

Blackstone Life Sciences agreed to give Merck $700 million to support its development of an investigational cancer drug called sacituzumab tirumotecan in exchange for low-to-mid-single-digit royalties ...

Merck said on Tuesday that it has entered into an agreement to receive funds managed by Blackstone Life Sciences for $700 ...

The results could help expand use of Welireg, one of the medicines Merck is counting on to drive revenue growth when its ...

A rising wave of tumor-agnostic therapies were one of ESMO’s themes, highlighted during the opening press conference by Toni ...

While most of what the FDA laid out in a recent draft guidance on the assessment of overall survival in oncology clinical ...

Iovance Biotherapeutics shares rose after the company received positive data from a clinical trial of its cancer treatment. Shares traded 11% higher ahead of the morning bell at $2.18.

Trump’s intervention on behalf of the ‘Dilbert’ creator and MAGA supporter sparked a range of reactions online.

The field of oncology continues to confront the formidable challenge of addressing cancer, a leading cause of mortality ...